Q linea

Q linea Tangible Book Value per Share

The Tangible Book Value per Share of Q linea (QLINEA.ST) as of Nov 20, 2026 is 51.75 SEK. In the previous year, Tangible Book Value per Share was -5.03 SEK — a change of -1,128.55% (higher).

Tangible Book Value per Share

51.75SEK

YoY

-1,128.55%

Last updated:

Tangible Book Value per Share of Q linea is 2025 51.75 SEK. Tangible Book Value per Share of Q linea was 2024 -5.03 SEK. It decreases by -1,128.55% higher compared to the previous year.

The Q linea Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
78.48 SEK
Jan 1, 2019
51.91 SEK
Jan 1, 2020
58.21 SEK
Jan 1, 2021
66.27 SEK
Jan 1, 2022
24.65 SEK
Jan 1, 2023
28.68 SEK
Jan 1, 2024
-5.03 SEK
Jan 1, 2025
51.75 SEK
The Q linea Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
51.75SEK-1,128.55%
-5.03SEK-117.54%
28.68SEK+16.35%
24.65SEK-62.80%
66.27SEK+13.84%
58.21SEK+12.14%
51.91SEK-33.85%
78.48SEK+212,150.00%
0.04SEK-97.18%
1.31SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Q linea Stock analysis

What does Q linea do? Q-linea AB develops and manufactures in-vitro diagnostic solutions for infectious diseases, focusing on antibiotic susceptibility testing. The company's core product, ASTar, is a fully-automated instrument that provides susceptibility profiles within three to six hours directly from positive blood cultures. This enables early targeted antibiotic administration for sepsis identification in hospital patients, primarily serving hospital laboratories. The firm measures bacteria's antimicrobial susceptibility using its own disposables, which are integral to the ASTar system's operation. Q-linea AB's revenue model is based on selling the ASTar instrument and its associated disposables to hospital laboratories. The company's product is specifically designed for sepsis identification in hospital settings, where rapid and accurate antibiotic susceptibility testing is critical. By providing a faster solution than traditional methods, Q-linea targets hospital labs seeking to improve patient outcomes in sepsis cases. The company operates as a holding company with a focus on developing and manufacturing IVD solutions. Its primary customers are hospital laboratories, which purchase the ASTar system and disposables to streamline their diagnostic processes. The firm's business model centers on the sale of both the instrument and the consumable disposables, creating recurring revenue streams from ongoing disposables usage. Q linea is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Q linea stock

Tangible Book Value per Share of Q linea is 51.75 SEK in 2025.

Tangible Book Value per Share of Q linea changed from -5.03 SEK to 51.75 SEK, representing a -1,128.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Q linea since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Q linea

All Key Metrics — Q linea